News & Updates
Filter by Specialty:
Arginine depletion plus chemo ups survival in rare lung cancer
In the pivotal phase II/III ATOMIC-Meso* trial, adding the first-in-class, arginine-depleting agent pegargiminase to standard first-line platinum-pemetrexed chemotherapy prolongs overall survival (OS) and progression-free survival (PFS) in patients with treatment-naïve, nonresectable, nonepithelioid pleural mesothelioma.
Arginine depletion plus chemo ups survival in rare lung cancer
31 May 2024
Antioxidant-rich diet in midlife helps ward off depression in later years
Middle-aged adults with high dietary antioxidant capacity appear to be better protected against the risk of late-life depression, according to a Singapore study, bolstering the recommendation for an antioxidant-rich diet to prevent depression in ageing populations.
Antioxidant-rich diet in midlife helps ward off depression in later years
30 May 2024
Musculoskeletal ultrasound for gout diagnosis: Why and how?
Musculoskeletal ultrasound (MSUS) is a convenient and effective imaging tool for detecting urate deposition in the joints of patients with gout and those with asymptomatic hyperuricaemia.
Musculoskeletal ultrasound for gout diagnosis: Why and how?
30 May 2024
Thyroid cancer patients with a history of breast cancer enjoy survival benefits
A history of breast cancer (BC) appears protective against mortality in patients with thyroid cancer (TC), suggests a study. This benefit is most pronounced with papillary TC (PTC) in patients who had TC first before BC (TC-1st patients), especially in those with a history of ER-positive BC.
